These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7055781)
1. Active specific immunotherapy of established micrometastases with BCG plus tumor cell vaccines: effective treatment of BCG side effects with isoniazid. Hanna MG; Pollack VA; Peters LC; Hoover HC Cancer; 1982 Feb; 49(4):659-64. PubMed ID: 7055781 [TBL] [Abstract][Full Text] [Related]
2. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery. Hanna MG; Peters LC Cancer; 1978 Dec; 42(6):2613-25. PubMed ID: 728864 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine. Hanna MG; Peters LC Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374 [TBL] [Abstract][Full Text] [Related]
4. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin. Minden P; Mathews HL Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072 [TBL] [Abstract][Full Text] [Related]
5. Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery. Zbar B; Canti G; Ashley MP; Rapp HJ; Hunter JT; Ribi E Cancer Res; 1979 May; 39(5):1597-603. PubMed ID: 427799 [No Abstract] [Full Text] [Related]
6. Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs. Peters LC; Hanna MG J Natl Cancer Inst; 1980 Jun; 64(6):1521-5. PubMed ID: 6990075 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response. Key ME; Hanna MG J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations. Bartlett GL; Kreider JW; Purnell DM; Katsilas DC Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867 [TBL] [Abstract][Full Text] [Related]
9. Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma. de Jong WH; Teppema JS; Wagenaar SS; Paques M; Steerenberg PA; Ruitenberg EJ Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 50(3):249-69. PubMed ID: 2870577 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery. Ashley MP; Zbar B; Hunter JT; Rapp HJ; Sugimoto T Cancer Res; 1980 Nov; 40(11):4197-203. PubMed ID: 7471060 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG. Tokunaga T; Taguchi S; Chino F; Murohashi T Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic effectiveness of BCG inactivated by various modalities. Kreider JW; Bartlett GL; Purnell DM Cancer; 1980 Aug; 46(3):480-7. PubMed ID: 7397622 [TBL] [Abstract][Full Text] [Related]
13. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG. Kataoka T; Tokunaga T; Murohashi T J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348 [TBL] [Abstract][Full Text] [Related]
14. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor. Jessup JM; Riggs CW; Hanna MG Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084 [No Abstract] [Full Text] [Related]
15. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients. Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei. Yarkoni E; Rapp HJ Oncology; 1982; 39(5):314-8. PubMed ID: 7099513 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma. Zbar B; Hunter J; Rapp HJ; Canti G Cancer; 1979 Feb; 43(2):484-91. PubMed ID: 421175 [TBL] [Abstract][Full Text] [Related]
18. [Growth of transplantable Guérin tumor and Morris hepatoma in rats after a single dose of BCG vaccine according to different timetables]. Nowak HF; Cylwik B; Zimnoch L; Jodczyk KJ; Pregowski W; Duda D; Bernaczyk A Patol Pol; 1981; 32(2):173-84. PubMed ID: 7322639 [No Abstract] [Full Text] [Related]
19. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases. Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146 [TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria. Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]